C12N 2501/21
Chemokines
Official title: Chemokines, e.g. MIP-1, MIP-2, RANTES, MCP, PF-4
C12N2501/21 (Chemokines) appears on 146 US grants and 220 published applications in this corpus.
Search patents in C12N- Granted patents
- 146
- Published applications
- 220
- Assignees
- 133
- Inventors
- 374
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1986 | 1 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 1 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 1 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 2 | 0 |
| 1996 | 0 | 0 |
| 1997 | 5 | 0 |
| 1998 | 5 | 0 |
| 1999 | 5 | 0 |
| 2000 | 3 | 0 |
| 2001 | 1 | 0 |
| 2002 | 1 | 2 |
| 2003 | 0 | 1 |
| 2004 | 1 | 3 |
| 2005 | 1 | 13 |
| 2006 | 1 | 13 |
| 2007 | 0 | 10 |
| 2008 | 2 | 3 |
| 2009 | 3 | 6 |
| 2010 | 7 | 14 |
| 2011 | 8 | 9 |
| 2012 | 9 | 8 |
| 2013 | 7 | 6 |
| 2014 | 8 | 7 |
| 2015 | 7 | 9 |
| 2016 | 8 | 4 |
| 2017 | 9 | 16 |
| 2018 | 2 | 11 |
| 2019 | 10 | 8 |
| 2020 | 10 | 12 |
| 2021 | 9 | 18 |
| 2022 | 1 | 8 |
| 2023 | 4 | 12 |
| 2024 | 5 | 4 |
| 2025 | 7 | 14 |
| 2026 | 2 | 9 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Composition for enhancing reprogramming efficiency from somatic cell to induced pluripotent stem cell, comprising mTOR activator, and method for enhancing reprogramming efficiency by using same6 Oct 2026US 12,753,394 B2Korea University Research and Business Foundation
- Method and apparatus for producing platelet and method for determining operating condition of apparatus for producing platelet14 Apr 2026US 12,600,948 B2Kyoto University
- Cellular targeted label delivery system2 Dec 2025US 12,485,192 B2Cellis AG
- Expansion of γδ T cells, compositions, and methods of use thereof4 Nov 2025US 12,458,698 B2GammaDelta Therapeutics Ltd
- Lyophilized compositions containing umbilical cord lining stem cells conditioned medium4 Nov 2025US 12,460,179 B2Restem LLC
- Methods and compositions related to platelet releasate and platelet-rich fibrin8 Oct 2026US 2026/0306546 A1Biobridge Global
- Method and apparatus for producing platelet and method for determining operating condition of apparatus for producing platelet3 Sep 2026US 2026/0258359 A1Kyoto University
- Pre-licensed composition and cell culture methods16 Jul 2026US 2026/0201337 A1Mesoblast International Sarl
- Rapid and deterministic generation of microglia from human pluripotent stem cells9 Jul 2026US 2026/0193605 A1WestfäLische Wilhelms-UniversitäT MüNster
- Expansion of gamma delta t cells, compositions, and methods of use thereof25 Jun 2026US 2026/0174861 A1GammaDelta Therapeutics Ltd
Most cited
By later US patents
- Treatment of retinitis pigmentosa with human umbilical cord cells175US 7,413,734 B2Ethicon, Inc. · 2008
- Method for culturing hematopoietic cells114US 5,460,964 ARegents of the University of Minnesota · 1995
- Ex vivo culture of stem cells105US 5,922,597 ARegents of the University of Minnesota · 1999
- Lipoprotein lipase suppression by endotoxin-induced mediator (shock assay)104US 4,603,106 AThe Rockefeller University · 1986
- Postpartum cells isolated from umbilical cord tissue, and methods of making and using the same84US 7,510,873 B2Ethicon, Inc. · 2009